
Infermedica is a global health tech company established in 2012. Its symptom checker and virtual triage tools provide accurate and efficient care to patients and members by helping them understand their symptoms and navigate complex healthcare systems to find the right level of care at the right time. Currently used by over 100 organizations in more than 30 countries and 24 languages, Infermedica’s symptom checker has performed more than 20 million health checkups to date. Infermedica tools are developed and maintained by a team of over 40 doctors, who have contributed over 120,000 physician work hours to ensure medical accuracy. Infermedica modules are certified Medical Devices in the EU and compliant with HIPAA and GDPR standards. Find out more at infermedica.com. Privacy policy: https://infermedica.com/privacy-policy

Infermedica is a global health tech company established in 2012. Its symptom checker and virtual triage tools provide accurate and efficient care to patients and members by helping them understand their symptoms and navigate complex healthcare systems to find the right level of care at the right time. Currently used by over 100 organizations in more than 30 countries and 24 languages, Infermedica’s symptom checker has performed more than 20 million health checkups to date. Infermedica tools are developed and maintained by a team of over 40 doctors, who have contributed over 120,000 physician work hours to ensure medical accuracy. Infermedica modules are certified Medical Devices in the EU and compliant with HIPAA and GDPR standards. Find out more at infermedica.com. Privacy policy: https://infermedica.com/privacy-policy
Founded: 2012
Headquarters / Origin: Poland (Wrocław)
Product focus: AI-powered symptom checker, virtual triage, patient intake APIs
Customers: B2B: insurers, providers, telemedicine, public health, pharma
Reported funding: About $45M (Series A + Series B)
| Company |
|---|
Symptom checking, virtual triage, and patient intake for healthcare organizations.
2012
Hospitals and Health Care
~10M
Reportedly ~USD 10M (Aug 6, 2020); participation from Karma Ventures, Inovo Venture Partners, Dreamit Ventures.
30M
USD 30M (Jan 25, 2022); participation from existing investors including Karma Ventures, EBRD, Heal Capital, Inovo Venture Partners.
“One Peak, EBRD, Heal Capital, Karma Ventures, Inovo Venture Partners”